Camberlogo (Camberlogo)
Eplerenone Tablet, Film Coated
Product Images NDC 31722-050
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Eplerenone (NDC 31722-050). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Eplerenonechemicalstrucyure (Eplerenonechemicalstructure)
Chemical structure of eplerenone, a corticosteroid-derived compound with multiple rings and functional groups, as shown in the diagram.*
Eplerenonefigure1 (Eplerenonefigure1)
A cumulative incidence curve graph comparing outcomes between EPLERENONE and placebo over 27 months. The x-axis represents months since randomization, and the y-axis shows cumulative incidence percentage. The graph includes a risk table for each group at various time points and displays statistical data (p-value and relative risk with confidence interval).*
Eplerenonefigure2 (Eplerenonefigure2)
A forest plot chart depicting hazard ratios with 95% confidence intervals for overall mortality and various subgroups such as age, gender, race, diabetes status, hypertension, Killip class, creatinine clearance, baseline beta blockers, ACE inhibitors, digoxin use, and diuretics, comparing Eplerenone versus placebo.*
Eplerenonefigure3 (Eplerenonefigure3)
A dose response scatter plot illustrating the reduction in systolic blood pressure (SBP) in mm Hg versus EPLERENONE daily dosage in mg. The graph compares placebo-subtracted adjusted mean changes from baseline across three hypertension studies: Study 1 QD, Study 2 QD, and Study 2 BID, with data points labeled accordingly.*
Eplerenonefigure4 (Eplerenonefigure4)
A dose-response scatter plot illustrating the effect of EPLERENONE on trough cuff diastolic blood pressure (DBP) reduction in hypertension studies. The x-axis shows EPLERENONE dose in mg/day, ranging from 0 to 200 mg, and the y-axis shows the reduction in DBP in mmHg from 0 to 10 mmHg. Data points represent results from three studies with different dosing schedules (Study 1 QD, Study 2 QD, Study 2 BID) indicated by distinct shapes.*
Eplerenonetablets25mg30scontainerlabel (Eplerenonetablets25mg30scontainerlabel)
Eplerenone Tablets 25 mg film-coated oral tablets in a 30-tablet package from Camber Pharmaceuticals, Inc. The label includes storage instructions, dosage advisory, barcode, and manufacturing details by Annora Pharma Pvt. Ltd.*
Eplerenonetablets50mg30scontainerlabel. (Eplerenonetablets50mg30scontainerlabel)
Label for Eplerenone tablets 50 mg by Camber Pharmaceuticals, Inc. The label states it contains 30 film-coated tablets for oral use. Storage instructions and contact information for Camber Pharmaceuticals and Annora Pharma Pvt. Ltd. are presented along with a barcode.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
